Medprin Regenerative Medical Technologies Co., Ltd. (SHE:301033)
74.11
+1.75 (2.42%)
At close: Jan 23, 2026
SHE:301033 Market Cap
SHE:301033 has a market cap or net worth of 4.94 billion as of January 23, 2026. Its market cap has increased by 61.28% in one year.
Market Cap
4.94B
Enterprise Value
4.69B
Revenue
336.73M
Ranking
n/a
PE Ratio
48.08
Stock Price
74.11
Market Cap Chart
Since July 26, 2021, SHE:301033's market cap has increased from 4.69B to 4.94B, an increase of 5.34%. That is a compound annual growth rate of 1.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 4.94B | 9.79% |
| Dec 31, 2025 | 4.50B | 61.81% |
| Dec 31, 2024 | 2.78B | -3.27% |
| Dec 29, 2023 | 2.88B | 18.06% |
| Dec 30, 2022 | 2.44B | -39.66% |
| Dec 31, 2021 | 4.04B | -13.95% |
| Jul 26, 2021 | 4.69B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GKHT Medical Technology | 5.65B |
| Nanjing Vishee Medical Technology | 5.50B |
| CareRay Digital Medical Technology | 5.21B |
| Wuhan Huakang Century Clean Technology | 5.12B |
| Hangzhou AGS MedTech | 5.11B |
| Zhejiang Orient Gene Biotech | 4.80B |
| Nanjing Medlander Medical Technology | 4.53B |
| Getein Biotech | 4.39B |